Broncus (堃博医疗) Pre-IPO: Big Potential to Be Tested
Broncus Holding is a leading interventional pulmonology company in China and globally. It has a leading position in the lung navigation system in...
830 Views
𝛼SK or SearchENTITY
Broncus (2216 HK)
Broncus (2216 HK)
21
Analysis
Health Care • China
Broncus is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company provides diagnostic solutions, lung cancer treatment solutions, and chronic obstructive pulmonary disease (COPD) solutions, including navigation platforms and interventional therapeutic devices like the InterVapor system and BroncAblate. Broncus was founded in 2012 and is headquartered in Hangzhou, China.
morex